PKCζ-IN-1 is a PKCζ -selective inhibitor with an IC 50 of 5.18 nM against human PKCζ . PKCζ-IN-1 also inhibits CDK2 with an IC 50 of 1.04 μM. PKCζ-IN-1 is applicable to research related to immune and inflammatory diseases.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > PKC | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.